3D ‘assembloid’ shows how SARS-CoV-2 infects brain cells
Researchers have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus that causes COVID-19, into the human brain.
Wall Street Has High Hopes for These 2 Unsung Stocks
Only one of them is moving higher on Friday, though.
Here’s Why FibroGen Stock Is Plunging Today
An FDA advisory committee made it clear that they don’t want the agency to approve roxadustat due to safety concerns.
Why Shopify Stock Jumped 29% in the First Half of 2021
The e-commerce giant is riding a wave of robust revenue and profit gains.
Why AMC Stock Is Plunging (Again) This Week, and Cineworld and Cinemark Are Following Suit
The meme stock movement is all but finished, pulling the rug out from underneath all the names swept up in the mania.
Why Ericsson Stock Is Tanking Today
The telecommunications equipment provider reports disappointing second-quarter results.
This Nasdaq Vaccine Stock Just Got a Big Boost — and Another Nasdaq Vaccine Stock Deserves the Credit
Find out why a big index move is so interesting for investors.
Why Virgin Galactic Stock Dropped Again Today
The space story pivoted from Virgin Galactic to Blue Origin this week.
Why Skillz Stock Dipped This Morning
The company will be issuing stock to redeem its public warrants.
Is Micron Technology Stock Headed to $165 a Share?
One analyst sees significant upside for this top producer of DRAM memory products.
Why Shares of Niu Technologies Sailed 16% Higher in the First Half of 2021
Electric-powered coupes and sedans aren’t the only sets of wheels that investors are charged up about.
Why 3D Systems Stock Is Plummeting This Week
Investors appear to be reacting to a rival’s recent acquisition.
4 Things Peloton Needs to Do to Become a Multibagger
Peloton is more than just an iPad-on-a-bike company.
Why Turquoise Hill Resources Stock Is Tumbling Today
The copper producer is facing some headwinds.
Why Bitcoin and Square Popped Today — But Dogecoin Dropped
Square’s a Bitcoin fan, but criticism from Dogecoin’s creator still stings.
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
After rallying on the coattails of Intelllia’s breakthrough, these companies have given back their June gains.
Levi Strauss’ Earnings Call: 3 Takeaways
Management has good reasons to upgrade its 2021 growth outlook after releasing its second-quarter results.